Trevi Therapeutics TRVI
NASDAQ TRVI
$17.26 +0.20 (+1.20%)
As of: Sep 4, 2026 · 3:59 PM EDT

Trevi Therapeutics (TRVI) Interest Coverage Ratio (QoQ) (2018 - 2022)

Analysis

Trevi Therapeutics (TRVI) Interest Coverage Ratio (QoQ) (2018 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Trevi Therapeutics 2.71 Bn 2.71 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 15.59%
Sep 30, 2022 -8.59%
Jun 30, 2022 -13.96%
Mar 31, 2022 13.12%
Dec 31, 2021 -16.77%
Sep 30, 2021 6.21%
Jun 30, 2021 11.15%
Mar 31, 2021 7.82%
Dec 31, 2020 39.02%
Jun 30, 2018 -236.20%